|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/127 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| A61K 9/51 | (2006.01) | ||
| A61K 51/1224 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61P 37/06 | (2018.01) | ||
| A61K 31/436 | (2006.01) | ||
| A61K 9/5123 | (2013.01) | ||
| A61P 37/06 | (2006.01) | ||
| A61K 9/1275 | (2013.01) | ||
| A61K 9/5169 | (2013.01) | ||
| A61K 9/0019 | (2013.01) | ||
| A61K 31/436 | (2013.01) |
| (11) | Number of the document | 3448364 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17790646.8 |
| Date of filing the European patent application | 2017-05-01 | |
| (97) | Date of publication of the European application | 2019-03-06 |
| (45) | Date of publication and mention of the grant of the patent | 2022-02-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/030444 |
| Date | 2017-05-01 |
| (87) | Number | WO 2017/190145 |
| Date | 2017-11-02 |
| (30) | Number | Date | Country code |
| 201662329676 P | 2016-04-29 | US |
| (72) |
MULDER, Willem , US
OCHANDO, Jordi , US
FAYAD, Zahi , US
BRAZA, Mounia , FR
DUIVENVOORDEN, Raphael , NL
FAY, Francois , US
|
| (73) |
Icahn School of Medicine at Mount Sinai ,
One Gustave L. Levy Place, New York, NY 10029,
US
|
| (54) | TARGETING THE INNATE IMMUNE SYSTEM TO INDUCE LONG-TERM TOLERANCE AND TO RESOLVE MACROPHAGE ACCUMULATION IN ATHEROSCLEROSIS |
| TARGETING THE INNATE IMMUNE SYSTEM TO INDUCE LONG-TERM TOLERANCE AND TO RESOLVE MACROPHAGE ACCUMULATION IN ATHEROSCLEROSIS |